MEDIA RELEASE PR37244
Elekta Compact Brings Radiation Therapy to Patients in India
HYDERABAD, Nov. 24 /PRNewswire-AsiaNet/ --
The Indo-American Cancer Institute and Research Center is the first in
India to treat cancer patients with Elekta Compact(TM), Elekta's robust,
cost-effective linear accelerator for radiation therapy that addresses the
cancer care needs of a wider population. The first patient treated on the
system was a 52-year-old woman with breast cancer.
Mohana Vamsy, MS, Mch, is Director and Chief Surgical Oncologist at the
Indo-American Cancer Institute. "Our first conventional treatment with
tangential fields took just eight minutes," says Dr. Vamsy. "It is a very
compact, user friendly machine."
In addition to Elekta Compact, the Institute is installing Elekta
Synergy(R) Platform, a unique digital linear accelerator that is X-ray Volume
Imaging (XVI)-ready. The Institute also utilizes Elekta Synergy(R) a digital
linear accelerator featuring full 3D imaging at the time of treatment. It was
the first clinical IMRT and IGRT system in India.
"Our decision to implement Elekta Compact was based on the performance of
Elekta Synergy," says Dr. Vamsy. "Elekta Compact is very reasonably priced as
well."
"We are excited and honored to partner with the Indo-American Cancer
Institute," stated Peter J. Gaccione, Vice President Global Sales Initiatives
for Elekta. "Elekta Compact has a much smaller footprint and its wide patient
clearance and compact head mean better clinical efficiency and patient
comfort. Patients receiving radical breast treatment, for instance, can raise
both arms above their heads during treatment," added Mr. Gaccione.
"It enables highly precise radiotherapy," says Krishnam Raju, MD, Head of
the Department of Radiation Oncology at the Indo-American Cancer Institute.
"The techniques are simple and efficient, for any indication site."
"Elekta Compact features very good performance," adds Muralidhar, PhD the
Indo-American Cancer Institute's Chief Medical Physicist. "We have a previous
history with Elekta, and appreciate Elekta's service and support. We compared
the system with linear accelerators from several other vendors before
deciding on Compact."
Because it is designed for demanding patient volume and efficient
throughput, the Indo-American Cancer Institute expects to treat up to 150
patients each week.
About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning systems
for radiation therapy and radiosurgery, as well as workflow enhancing
software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to both
healthcare providers and patients, Elekta aims to improve, prolong and even
save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution from the Elekta
Group.
Elekta employs around 2,500 employees globally. The corporate headquarter
is located in Stockholm, Sweden, and the company is listed on the Nordic
Exchange under the ticker EKTAb. For more information about Elekta, please
SOURCE: Elekta
NOTE TO EDITORS: Images of Elekta Compact are available on Flickr
CONTACT: Stina Thorman,
Investor Relations,
Elekta AB,
+46 8 587 254 37,
+46 70 778 60 10,
stina.thorman@elekta.com;
or Michelle Lee,
Director,
Marketing Services,
Elekta Inc.,
+1-770-670-2447,
michelle.lee@elekta.com
NEWS 
